相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Angelique Gougelet et al.
GUT (2016)
miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth
Yuyan Han et al.
JOURNAL OF HEPATOLOGY (2016)
miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis
Tingting Huang et al.
MOLECULAR CANCER (2016)
Hsa-miR-375 is a predictor of local control in early stage breast cancer
Franz Zehentmayr et al.
CLINICAL EPIGENETICS (2016)
Growth and fatty acid characterization of microalgae isolated from municipal waste-treatment systems and the potential role of algal-associated bacteria in feedstock production
Kevin Stemmler et al.
PEERJ (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
Wei Kang et al.
MOLECULAR CANCER (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Gene Ontology Consortium: going forward
J. A. Blake et al.
NUCLEIC ACIDS RESEARCH (2015)
ArrayExpress update-simplifying data submissions
Nikolay Kolesnikov et al.
NUCLEIC ACIDS RESEARCH (2015)
Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis
XiaoTian Zhang et al.
PLOS ONE (2015)
Insulin-Like Growth Factor-II mRNA-Binding Protein 3 Expression in Effusion Cytology: A Marker for Metastatic Adenocarcinoma Cells and a Potential Prognostic Indicator in Gastric Adenocarcinoma
Hye Jeong Kim et al.
ACTA CYTOLOGICA (2014)
IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status
Emanuel Adelino M. Damasceno et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis
Wei Kang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma
Wei Kang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
被撤回的出版物: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Retracted article. See vol. 582, pg. 134, 2020)
Jing Y. Krzeszinski et al.
NATURE (2014)
Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization
T. Rivera Vargas et al.
ONCOGENE (2014)
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino et al.
PLOS ONE (2014)
miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway
Weiguo Cao et al.
TUMOR BIOLOGY (2014)
IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development
Lars Jonson et al.
CELL REPORTS (2014)
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
Immacolata Scognamiglio et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains
Kristin Wächter et al.
BIOLOGICAL CHEMISTRY (2013)
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Pengcheng Bu et al.
CELL STEM CELL (2013)
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression
Sanjoy Samanta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
T. S. Clauditz et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
Paul Lochhead et al.
EUROPEAN JOURNAL OF CANCER (2012)
Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma
Kaoru Okada et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
MicroRNAs in metabolism and metabolic disorders
Veerle Rottiers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
S. Samanta et al.
ONCOGENE (2012)
Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells
Arisa Ueki et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Classification OMS 2010 des tumeurs digestives : la quatrième édition
Jean-François Fléjou
ANNALES DE PATHOLOGIE (2011)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology
Jennifer J. Findeis-Hosey et al.
HUMAN PATHOLOGY (2011)
Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
Ramaswamy Suvasini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
Dawei Li et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
Queenie W. -L. Wong et al.
GASTROENTEROLOGY (2008)
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
Yung-Ming Jeng et al.
HEPATOLOGY (2008)
IMP-3 is a novel progression marker in malignant melanoma
Jennifer G. Pryor et al.
MODERN PATHOLOGY (2008)
Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis
B. H. Liu et al.
ONCOGENE (2008)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
L523S, an RNA-binding protein as a potential therapeutic target for lung cancer
T Wang et al.
BRITISH JOURNAL OF CANCER (2003)
分享论文
